The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

T-Lymphocytes, Cytotoxic

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of T-Lymphocytes, Cytotoxic


Psychiatry related information on T-Lymphocytes, Cytotoxic


High impact information on T-Lymphocytes, Cytotoxic


Chemical compound and disease context of T-Lymphocytes, Cytotoxic


Biological context of T-Lymphocytes, Cytotoxic


Anatomical context of T-Lymphocytes, Cytotoxic


Associations of T-Lymphocytes, Cytotoxic with chemical compounds


Gene context of T-Lymphocytes, Cytotoxic


Analytical, diagnostic and therapeutic context of T-Lymphocytes, Cytotoxic


  1. Phenotypic heterogeneity of cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell clones. Sethi, K.K., Näher, H., Stroehmann, I. Nature (1988) [Pubmed]
  2. Cytotoxic T lymphocyte recognition of transfected cells expressing a cloned retroviral gene. Flyer, D.C., Burakoff, S.J., Faller, D.V. Nature (1983) [Pubmed]
  3. Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Cox, J.H., Yewdell, J.W., Eisenlohr, L.C., Johnson, P.R., Bennink, J.R. Science (1990) [Pubmed]
  4. Human CD8+ T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)-containing protein requires exogenous processing. Blake, N., Lee, S., Redchenko, I., Thomas, W., Steven, N., Leese, A., Steigerwald-Mullen, P., Kurilla, M.G., Frappier, L., Rickinson, A. Immunity (1997) [Pubmed]
  5. Oscillating CD8(+) T cell effector functions after antigen recognition in the liver. Isogawa, M., Furuichi, Y., Chisari, F.V. Immunity (2005) [Pubmed]
  6. Stress presents a problem for dendritic cells: Corticosterone and the fate of MHC class I antigen processing and presentation. Truckenmiller, M.E., Bonneau, R.H., Norbury, C.C. Brain Behav. Immun. (2006) [Pubmed]
  7. No evidence for an association of the CTLA4 gene with bipolar I disorder. Jun, T.Y., Lee, K.U., Pae, C.U., Kweon, Y.S., Chae, J.H., Bahk, W.M., Kim, K.S., Lew, T.Y., Han, H. Psychiatry and clinical neurosciences. (2004) [Pubmed]
  8. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Trinchieri, G. Annu. Rev. Immunol. (1995) [Pubmed]
  9. Roles of alpha beta and gamma delta T cell subsets in viral immunity. Doherty, P.C., Allan, W., Eichelberger, M., Carding, S.R. Annu. Rev. Immunol. (1992) [Pubmed]
  10. Identification of a Tap-dependent leader peptide recognized by alloreactive T cells specific for a class Ib antigen. Aldrich, C.J., DeCloux, A., Woods, A.S., Cotter, R.J., Soloski, M.J., Forman, J. Cell (1994) [Pubmed]
  11. H-2M3 presents a Listeria monocytogenes peptide to cytotoxic T lymphocytes. Pamer, E.G., Wang, C.R., Flaherty, L., Lindahl, K.F., Bevan, M.J. Cell (1992) [Pubmed]
  12. A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with the cytolysin/perforin gene. Shiver, J.W., Henkart, P.A. Cell (1991) [Pubmed]
  13. Cytotoxic T lymphocyte hybridomas that mediate specific tumor-cell lysis in vitro. Kaufmann, Y., Berke, G., Eshhar, Z. Proc. Natl. Acad. Sci. U.S.A. (1981) [Pubmed]
  14. Recombinant viruses expressing a human malaria antigen can elicit potentially protective immune CD8+ responses in mice. Miyahira, Y., García-Sastre, A., Rodriguez, D., Rodriguez, J.R., Murata, K., Tsuji, M., Palese, P., Esteban, M., Zavala, F., Nussenzweig, R.S. Proc. Natl. Acad. Sci. U.S.A. (1998) [Pubmed]
  15. Cross-reactivity of anti-CD3/IL-2 activated effector cells derived from lymph nodes draining heterologous clones of a murine tumor. Matsumura, T., Krinock, R.A., Chang, A.E., Shu, S. Cancer Res. (1993) [Pubmed]
  16. Il-4 therapy prevents the development of proteinuria in active Heymann nephritis by inhibition of Tc1 cells. Spicer, S.T., Ha, H., Boyd, R.A., He, X.Y., Carter, N., Tran, G., Penny, M.J., Hodgkinson, S.J., Hall, B.M. J. Immunol. (2001) [Pubmed]
  17. Effect of Bacillus Calmette-Guérin on the in vitro generation of cytotoxic T lymphocytes. I. Effect of BCG on the frequency of cytotoxic T lymphocyte precursors and on the production of helper factors. Kendall, L., Sabbadini, E. J. Immunol. (1981) [Pubmed]
  18. H-2M3 encodes the MHC class I molecule presenting the maternally transmitted antigen of the mouse. Wang, C.R., Loveland, B.E., Lindahl, K.F. Cell (1991) [Pubmed]
  19. Downregulation of L3T4+ cytotoxic T lymphocytes by interleukin-2. Shih, C.C., Truitt, R.L. Science (1987) [Pubmed]
  20. Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Sarin, A., Williams, M.S., Alexander-Miller, M.A., Berzofsky, J.A., Zacharchuk, C.M., Henkart, P.A. Immunity (1997) [Pubmed]
  21. Supraoptimal peptide-major histocompatibility complex causes a decrease in bc1-2 levels and allows tumor necrosis factor alpha receptor II-mediated apoptosis of cytotoxic T lymphocytes. Alexander-Miller, M.A., Derby, M.A., Sarin, A., Henkart, P.A., Berzofsky, J.A. J. Exp. Med. (1998) [Pubmed]
  22. Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. Jäger, E., Jäger, D., Karbach, J., Chen, Y.T., Ritter, G., Nagata, Y., Gnjatic, S., Stockert, E., Arand, M., Old, L.J., Knuth, A. J. Exp. Med. (2000) [Pubmed]
  23. Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Erickson, S.L., de Sauvage, F.J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheehan, K.C., Schreiber, R.D., Goeddel, D.V., Moore, M.W. Nature (1994) [Pubmed]
  24. Inhibition of the alloantibody response by CD95 ligand. Arai, H., Chan, S.Y., Bishop, D.K., Nabel, G.J. Nat. Med. (1997) [Pubmed]
  25. Molecular mimicry mediated by MHC class Ib molecules after infection with gram-negative pathogens. Lo, W.F., Woods, A.S., DeCloux, A., Cotter, R.J., Metcalf, E.S., Soloski, M.J. Nat. Med. (2000) [Pubmed]
  26. Positive selection of T lymphocytes on fibroblasts. Pawlowski, T., Elliott, J.D., Loh, D.Y., Staerz, U.D. Nature (1993) [Pubmed]
  27. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Tomer, Y., Davies, T.F. Endocr. Rev. (2003) [Pubmed]
  28. Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody. Perez, P., Hoffman, R.W., Shaw, S., Bluestone, J.A., Segal, D.M. Nature (1985) [Pubmed]
  29. Induction of human autologous cytotoxic T lymphocytes on formalin-fixed and paraffin-embedded tumour sections. Liu, S.Q., Saijo, K., Todoroki, T., Ohno, T. Nat. Med. (1995) [Pubmed]
  30. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes. Yewdell, J.W., Bennink, J.R. Science (1989) [Pubmed]
  31. Cyclophosphamide-sensitive T lymphocytes suppress the in vivo generation of antigen-specific cytotoxic T lymphocytes. Röllinghoff, M., Starzinski-Powitz, A., Pfizenmaier, K., Wagner, H. J. Exp. Med. (1977) [Pubmed]
  32. Granzyme A is an interleukin 1 beta-converting enzyme. Irmler, M., Hertig, S., MacDonald, H.R., Sadoul, R., Becherer, J.D., Proudfoot, A., Solari, R., Tschopp, J. J. Exp. Med. (1995) [Pubmed]
  33. Ham-2 corrects the class I antigen-processing defect in RMA-S cells. Attaya, M., Jameson, S., Martinez, C.K., Hermel, E., Aldrich, C., Forman, J., Lindahl, K.F., Bevan, M.J., Monaco, J.J. Nature (1992) [Pubmed]
  34. The T lymphocyte glycoprotein CD2 binds the cell surface ligand LFA-3. Selvaraj, P., Plunkett, M.L., Dustin, M., Sanders, M.E., Shaw, S., Springer, T.A. Nature (1987) [Pubmed]
  35. CTLA-4: new insights into its biological function and use in tumor immunotherapy. Egen, J.G., Kuhns, M.S., Allison, J.P. Nat. Immunol. (2002) [Pubmed]
  36. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation. Gilfillan, S., Ho, E.L., Cella, M., Yokoyama, W.M., Colonna, M. Nat. Immunol. (2002) [Pubmed]
  37. B7-1 engagement of cytotoxic T lymphocyte antigen 4 inhibits T cell activation in the absence of CD28. Fallarino, F., Fields, P.E., Gajewski, T.F. J. Exp. Med. (1998) [Pubmed]
  38. A new H-2-linked class I gene whose expression depends on a maternally inherited factor. Lindahl, K.F., Hausmann, B., Chapman, V.M. Nature (1983) [Pubmed]
  39. CTLA-4-Ig activates forkhead transcription factors and protects dendritic cells from oxidative stress in nonobese diabetic mice. Fallarino, F., Bianchi, R., Orabona, C., Vacca, C., Belladonna, M.L., Fioretti, M.C., Serreze, D.V., Grohmann, U., Puccetti, P. J. Exp. Med. (2004) [Pubmed]
  40. Disruption of lymphocyte function and signaling in CD45-associated protein-null mice. Matsuda, A., Motoya, S., Kimura, S., McInnis, R., Maizel, A.L., Takeda, A. J. Exp. Med. (1998) [Pubmed]
  41. Cells expressing a major histocompatibility complex class I molecule with a single covalently bound peptide are highly immunogenic. Mottez, E., Langlade-Demoyen, P., Gournier, H., Martinon, F., Maryanski, J., Kourilsky, P., Abastado, J.P. J. Exp. Med. (1995) [Pubmed]
  42. Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy. Jicha, D.L., Mulé, J.J., Rosenberg, S.A. J. Exp. Med. (1991) [Pubmed]
WikiGenes - Universities